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Abstract
Introduction: Improved pneumonia diagnostics are needed in low‐resource settings
(LRS); lung ultrasound (LUS) is a promising diagnostic technology for pneumonia. The
objective was to compare LUS versus chest radiograph (CXR), and among LUS inter-
preters, to compare expert versus limited training with respect to interrater reliability.
Methods: We conducted a prospective, observational study among children with
World Health Organization (WHO) Integrated Management of Childhood Illness
(IMCI) chest‐indrawing pneumonia at two district hospitals in Mozambique and
Pakistan, and assessed LUS and CXR examinations. The primary endpoint was in-
terrater reliability between LUS and CXR interpreters for pneumonia diagnosis
among children with WHO IMCI chest‐indrawing pneumonia.
Results: Interrater reliability was excellent for expert LUS interpreters, but poor to
moderate for expert CXR interpreters and onsite LUS interpreters with limited training.
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Conclusions: Among children with WHO IMCI chest‐indrawing pneumonia, expert
interpreters may achieve substantially higher interrater reliability for LUS compared
to CXR, and LUS showed potential as a preferred reference standard. For point‐of‐
care LUS to be successfully implemented for the diagnosis and management of
pneumonia in LRS, the clinical environment and amount of appropriate user training
will need to be understood and addressed.
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1 | INTRODUCTION
Each year, approximately 920,000 children die before their fifth birthdays
due to pneumonia.1 Greater access to appropriate and effective pneu-
monia diagnostics, particularly in low‐resource settings (LRS), is critical to
addressing child mortality. In LRS, pneumonia is identified using the
World Health Organization (WHO) IntegratedManagement of Childhood
Illness (IMCI) guidelines that depend on assessing variable and subjective
clinical signs, specifically respiratory rate and chest indrawing.2 It is not
clear how effective WHO IMCI guidelines are in identifying pneumonia,3
and because the guidelines prioritize diagnostic sensitivity over specifi-
city, there is concern regarding antimicrobial overuse and resistance.4
Diagnostic alternatives to WHO IMCI also have challenges.5 Clinical di-
agnosis not using WHO IMCI guidelines lack standardization. If available,
chest radiographs (CXR) can be expensive, difficult to obtain, time‐
consuming, and expose the child to ionizing radiation.5–7 Microbiology
(e.g., blood, lung/pleural aspiration, and/or bronchoalveolar lavage cul-
ture) is invasive, slow, and detects a limited proportion of cases.5 Bio-
markers such as C‐reactive protein can correlate with bacterial infection
but do not have a set threshold nor indicate a specific etiology.5 Given
these limitations and that diagnostic tests used for pediatric pneumonia
have not been sufficiently validated despite their routine use, there is no
satisfying safe and effective reference standard for the accurate and
reliable diagnosis of pediatric pneumonia.8 Lung ultrasound (LUS) is a
promising technology that can dynamically visualize the lungs with po-
tentially high diagnostic accuracy for pneumonia.6 Advantages of LUS,
relative to CXR, include its lower cost, portability, ease of use, and ab-
sence of ionizing radiation.6,7,9 We conducted a pilot study in Mozambi-
que and Pakistan to investigate the use of point‐of‐care LUS as a tool for
the diagnosis of pediatric pneumonia in LRS among children with WHO
IMCI chest‐indrawing pneumonia.
2 | METHODS
2.1 | Study design, setting, and participants
The methods of this study have been described previously.10 The
primary aim of this prospective facility‐based cohort study is to
provide evidence regarding the use of LUS as a diagnostic tool for
pneumonia in children presenting to district hospitals in Manhiça,
Mozambique and Karachi, Pakistan. We investigated whether inter-
rater reliability was similar among LUS interpreters and among CXR
interpreters.
Children aged 2–23 months meeting the WHO IMCI chest‐
indrawing pneumonia case definition in the outpatient and/or
emergency departments of Manhiça District Hospital, a low‐volume,
rural hospital in Manhiça and Sindh Government Children's
Hospital–Poverty Eradication Initiative, a high‐volume, urban hospi-
tal in Karachi, were screened by study staff to determine eligibility
(Table 1; Figure 1). The study was conducted in accordance with the
International Conference on Harmonisation, Good Clinical Practice,
and the Declaration of Helsinki 2008, and was approved by the
Western Institutional Review Board in the state of Washington; the
Comité Institucional de Bioética em Saúde do Centro de Investigação
em Saúde de Manhiça (Manhiça); the Comité Nacional de Bioética em
Saúde (Maputo, Mozambique; Ref. 246/CNBS/17); the Comite de
Ética del Hospital Clínic de Barcelona (Barcelona, Spain); and the Aga
Khan University Ethics Review Committee (Karachi). This study was
registered NCT03187067 with ClinicalTrials.gov.
2.2 | Study procedures
On Day 1, after enrollment, eligible children underwent a history and
physical examination as well as CXR and LUS collection. All enrolled
children received a local standard of care without the results of the
LUS examinations informing clinical care.
LUS examinations (longitudinal and oblique scans obtained of the
anterior, lateral, and posterior sides of the child's chest [Figure 2])
were performed by nonphysician healthcare personnel (a nurse and a
medical agent in Mozambique, and two radiology technicians in Pa-
kistan) who received a 1‐day standardized training course as well as
3 days of supervised practice before the initiation of study activities.
LUS interpretation using a standardized scoresheet targeted the
detection of typical lung consolidations and/or pleural effusions. At
least two independent physicians extensively trained in LUS (expert
LUS interpreters) and blinded to clinical presentation interpreted
each examination. If discordant, a designated expert LUS interpreter
acted as a tiebreaker. LUS operators at each site also independently
from one another interpreted LUS scans in batches at a later time
using the same standardized scoresheet.
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CXR images were collected based on the standard practice at
each study site. A CXR interpretation panel of six expert inter-
preters, comprised of four radiologists, one pediatric pulmonolo-
gist, and one pediatric infectious diseases physician, investigated
radiographic indicators of primary endpoint pneumonia, in a pro-
cess modeled after the WHO CXR standardized interpretation
process which focused on the presence of consolidation, in-
filtrates, and/or effusion.11–14 To qualify as an expert CXR inter-
preter, each member of the panel had trained in and previously
performed WHO CXR interpretation, and in preparation for this
study, achieved a score of at least 80% sensitivity and 80% spe-
cificity in the interpretation of a testing set of 25 CXRs from the
WHO CXR in epidemiological studies series. For a final expert CXR
diagnosis, at least three members of the study's CXR interpreta-
tion panel independently interpreted each CXR. In situations
where there were more than three interpreters, three inter-
pretations were randomly selected, and if the first two inter-
pretations were discordant, the third would act as a tiebreaker.
TABLE 1 Study definitions and eligibility criteria
Definitions
Fast breathing for age • Children 2 to <12 months of age: RR ≥50 breaths per minute
• Children ≥12 months of age: RR ≥40 breaths per minute
Severe respiratory distress Grunting, nasal flaring, and/or head nodding
WHO IMCI general danger signs Lethargy or unconsciousness, convulsions, vomiting everything, inability to drink or breastfeed
Eligibility criteria
Inclusion criteria • 2–23 months of age
• Cough <14 days or difficulty breathing
• Visible indrawing of the chest wall with or without fast breathing for age
• Ability and willingness of child's caregiver to provide informed consent and to be available for follow‐up for
the planned duration of the study, including accepting a home visit if he/she fails to return for a scheduled
study follow‐up visit
Exclusion criteria • Resolution of chest indrawing after bronchodilator challenge, if wheezing at screening examination
• Severe respiratory distress
• arterial Spo2 <90% in room air, as assessed noninvasively by a pulse oximeter
• WHO IMCI general danger signs
• Stridor when calm
• Known or possible tuberculosis (history of a cough ≥14 days)
• Any medical or psychosocial condition or circumstance that, in the opinion of the investigators, would
interfere with the conduct of the study or for which study participation might jeopardize the child's health
• Living outside the study catchment area
Abbreviations: IMCI, Integrated Management of Childhood Illness; RR, respiratory rate; SpO2, oxyhemoglobin saturation; WHO, World Health
Organization.
F IGURE 1 Flowchart of study participants by country: Mozambique (M), Pakistan (P)
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2.3 | Outcomes
The primary outcome was LUS findings among children with
WHO IMCI chest‐indrawing pneumonia upon enrollment. We
focus here on pneumonia as assessed by expert LUS interpreters,
LUS interpreters with limited training, and expert CXR inter-
preters, and compare interrater reliability between these
interpreters.
2.4 | Statistical analysis
Agreement of the LUS and CXR imaging modalities regarding the
primary endpoint of pneumonia was estimated using Cohen's κ,
based on the expert LUS interpreters, LUS interpreters with limited
training, and expert CXR interpreters. For both LUS and CXR images,
expert interpreters were compared to each other. For LUS images,
expert interpreters were also compared to onsite interpreters with
F IGURE 2 Lung ultrasound examinations consisted of longitudinal and oblique scans obtained of the anterior, lateral, and posterior sides of
the child's chest
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limited training. All analyses were performed using R (version 3.5.1; R
Foundation for Statistical Computing).
3 | RESULTS
Enrollment began in August 2017 in Mozambique and October 2017
in Pakistan. The last visits were completed in June 2018 in Mo-
zambique and April 2018 in Pakistan. In total, 1867 (256 in Mo-
zambique; 1611 in Pakistan) children were screened, of which 230
were enrolled, 1475 were ineligible, 99 were eligible but refused
enrollment consent, and 63 were not enrolled for other reasons (e.g.,
the caregiver was under 18 years of age; Figure 1). The most fre-
quent reason for ineligibility at both sites was a lack of chest in-
drawing (70 in Mozambique; 1318 in Pakistan). LUS and CXR imaging
were available for 220 children. Baseline characteristics of children
with WHO IMCI chest‐indrawing pneumonia are presented by
country in Table 2. Numbers of LUS and CXR pneumonia determi-
nations as classified by expert LUS and expert CXR interpreters are
presented by country in Table A1 and graphically in Figure 3. LUS
identified 9 of 18 (Mozambique) and 11 of 13 (Pakistan) CXR‐
confirmed cases and identified 6 (Mozambique) and 45 (Pakistan)
additional cases not confirmed by CXR. CXR‐confirmed pneumonia
was identified in 18.6% (18/97) of children in Mozambique and in
10.6% (13/123) of children in Pakistan. The agreement between LUS
and CXR was poor to moderate (κ = 0.178 for Pakistan and κ = 0.453
for Mozambique).
As shown in Table 3a, the expert LUS interpreters demonstrated
excellent interrater reliability with κ = 0.914, while the interrater
reliability among onsite and between onsite and expert LUS inter-
preters varied substantially (κ from 0.196 to 0.983; cross‐classified
counts comparing LUS interpreters are shown in Tables A2–A4).
Onsite LUS interpreters in Mozambique diagnosed pneumonia 0.5
times or less frequently than expert LUS interpreters (7.2% and 2.1%
for onsite interpreters A and B vs. 15.5% for final expert LUS in-
terpretation). Onsite LUS interpreters in Pakistan diagnosed pneu-
monia about 1.4 times more frequently than expert LUS interpreters
(62.6% and 63.4% for onsite interpreters C and D vs. 45.5% for final
expert LUS interpretation; Table A3). As shown in Table 3b, the in-
terrater reliability observed between expert CXR interpreters for
whom more than 10 paired interpretations were available varied
widely ranging from very poor to moderate (κ from −0.036 to 0.619).
When restricted to the same subsets of scans as used by each pair of
CXR interpreters, the kappa estimates for the two experts LUS in-
terpreters were substantially higher (all >0.80 and most >0.90) than
the corresponding kappa estimates for the expert CXR interpreters.
4 | DISCUSSION
LUS demonstrated excellent interrater reliability between the expert
LUS interpreters in diagnosing pneumonia. There was almost uni-
formly higher interrater reliability in diagnosing pneumonia between
expert LUS interpreters than among onsite LUS interpreters with
limited LUS training or among expert CXR interpreters. While
Pakistan onsite LUS interpreters demonstrated high interrater re-
liability with each other and moderate interrater reliability with the
expert LUS interpreters, Mozambique onsite LUS interpreters did
not. Compared with the expert LUS interpreters, it appeared the
Pakistan onsite LUS interpreters diagnosed pneumonia more fre-
quently and the Mozambique onsite LUS interpreters diagnosed
pneumonia less frequently. This discrepancy may be the result of
increased disease burden and pathology in Pakistan or that more
children were screened in the high‐volume urban hospital in Pakistan
which resulted in the onsite LUS interpreters seeing more pathology
on LUS compared with the onsite LUS interpreters in the low‐
volume rural district hospital in Mozambique. In Mozambique, it may
be that the onsite interpreters saw less pneumonia and less pathol-
ogy on LUS, and, thus, were less familiar and less able to identify
pneumonia on LUS, while in Pakistan, given their increased familiarity
with abnormal LUS findings, the onsite interpreters overdiagnosed
pneumonia on LUS compared to expert LUS interpreters.
In considering the differences in LUS performance between the
sites in Mozambique and Pakistan and the potential use case for LUS
as a diagnostic or screening tool in LRS, we need to consider factors,
such as differing epidemiologies, severities, and presentations of
disease, various comorbidities, such as HIV, malaria, and malnutrition,
variable LUS operator/interpreter skill levels (nonphysician clinicians
in Mozambique and technicians with previous ultrasound experience
in Pakistan), and varying healthcare levels (low‐volume rural district
hospital in Mozambique and high‐volume urban hospital in Pakistan),
among others. For example, with minimal training, LUS may be an
appropriate tool for use by technicians, while more training may be
required for use by some clinicians,15,16 particularly if they use this
tool infrequently. Of note, all the onsite LUS operators after a short,
limited but focused training were capable of obtaining quality LUS
videos that the expert LUS interpreters could reliably interpret
TABLE 2 Baseline characteristics of children with World Health
Organization Integrated Management of Childhood Illness
chest‐indrawing pneumonia at enrollment by country
Mozambique Pakistan
N = 97 N = 123
Age (months)
Mean (SD) 10.90 (6.02) 6.65 (4.68)
<12, n (%) 54 (55.7) 108 (87.8)
Female, n (%) 39 (40.2) 31 (25.2)
Temperature (°C), mean (SD) 37.06 (1.09) 36.73 (0.76)
Fever (≥38°C), n (%) 21 (21.6) 11 (8.9)
Respiratory rate (breaths/min)
<12 months, mean (SD) 52.87 (11.20) 53.44 (7.92)
≥12 months, mean (SD) 44.26 (10.00) 48.13 (10.06)
Tachypnea, n (%) 52 (53.6) 79 (64.2)
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remotely. Thus, LUS operation and use may be feasible at many
healthcare levels, but LUS interpretation may be more restricted in
the absence of access to adequately trained interpreters or auto-
mated interpretation through machine learning. For point‐of‐care
LUS to be successfully implemented for the diagnosis and manage-
ment of pneumonia in LRS, the clinical environment and the appro-
priate amount of user training will need to be understood and
addressed.
Higher interoperator and interrater reliability for LUS inter-
pretation than for CXR interpretation in identifying pediatric pneu-
monia is supported by the literature (Figure 4).14,16–33 We contrasted
kappas observed in this study with kappas observed in the literature
among other LUS and CXR interpreters. Kappas between LUS
interpreters were 0.900 (in Pakistan) and 0.917 (in Mozambique) in
this study (expert LUS interpreters) and ranged from 0.635 to 0.930
in the literature, whereas kappa between CXR interpreters ranged
from −0.04 to 0.62 in this study and from 0.35 to 0.74 in the
literature.
F IGURE 3 Graphical representation of a number of children diagnosed with chest‐indrawing pneumonia by World Health Organization
(WHO) Integrated Management of Childhood Illness (IMCI) criteria, chest radiograph (CXR), and/or lung ultrasound (LUS) in Mozambique and
Pakistan
TABLE 3a Interrater reliability among lung ultrasound (LUS)
interpreters
LUS interpreter 1 LUS interpreter 2 N κ estimate
Expert LUS 1 Expert LUS 2 220 0.914
Expert LUS finala Onsite LUS
Mozambique A
97 0.597
Expert LUS finala Onsite LUS
Mozambique B
97 0.206
Expert LUS finala Onsite LUS Pakistan C 123 0.634
Expert LUS finala Onsite LUS Pakistan D 123 0.619
Onsite LUS
Mozambique A
Onsite LUS
Mozambique B
97 0.196
Onsite LUS Pakistan C Onsite LUS Pakistan D 123 0.983
aExpert LUS final interpretations are identical to expert LUS 1 and expert
LUS 2 interpretations when they agree, and when they did not agree, are
determined by the majority interpretation involving a third tiebreaker
expert LUS interpreter.
TABLE 3b Interrater reliability among chest radiograph (CXR)
expert interpreters
CXR
interpreter 1
CXR
interpreter 2 N
CXR κ
estimate
LUS κ
estimatea
Expert CXR 1 Expert CXR 2 118 0.401 0.958
Expert CXR 1 Expert CXR 3 10 1b 1
Expert CXR 1 Expert CXR 4 130 0.378 0.94
Expert CXR 1 Expert CXR 5 65 0.242 0.938
Expert CXR 1 Expert CXR 6 32 0.619 0.929
Expert CXR 2 Expert CXR 3 21 0.488 0.897
Expert CXR 2 Expert CXR 4 162 0.507 0.906
Expert CXR 2 Expert CXR 5 52 −0.036 0.876
Expert CXR 2 Expert CXR 6 62 0.403 0.934
Expert CXR 3 Expert CXR 4 24 0.318 0.909
Expert CXR 3 Expert CXR 5 4 1b 1
Expert CXR 4 Expert CXR 5 64 0.031 0.83
Expert CXR 4 Expert CXR 6 63 0.323 0.935
aLUS kappa estimates are based on expert LUS 1 and expert LUS 2
evaluations of LUS from Table 3a, but restricted to the same subset of
children as the expert CXR interpretations noted in the first two columns.
bKappa estimates of 1 for expert CXR interpreters 1 versus 3 and 3
versus 5 were based on small numbers of interpretations (10 and 4,
respectively).
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As demonstrated in this pilot with poor‐to‐moderate interrater
reliability even among trained expert CXR interpreters, CXR itself is
an imperfect reference standard, and, therefore, limited our ability to
accurately assess LUS performance. Compelling evidence indicates
that LUS may have greater sensitivity or specificity when compared
with CXR, a diagnostic not readily available in LRS.6,22,26,28,34,35 In-
itially, we considered analyzing the data using CXR as the reference
standard (Table A5). However, CXR is a poor reference standard, and
diagnosing pediatric pneumonia when there is no proven accurate
and reliable gold standard is problematic.8 The true positive rate,
false‐positive rate, positive predictive value, and negative predictive
value for LUS in comparison to CXR in our study was a mix of rela-
tively good as well as relatively poor statistics which we believe could
be due to CXR being a relatively poor reference standard. Of note,
despite being used widely for epidemiologic and vaccine effective-
ness studies, the current WHO CXR interpretation methodology is
not intended for clinical use; rather it is intended to serve as a re-
search endpoint.11
Limitations to this pilot included the small sample size and
sampling strategy, and employing different cadres of LUS users be-
tween the sites. This study design and analysis only included children
who met the WHO IMCI chest‐indrawing pneumonia criteria, and,
thus, did not allow us to investigate the sensitivity or specificity of
these criteria themselves. Along with the different underlying
pneumonia epidemiologies, because the study sites and the popula-
tions were different between the two and the sample sizes of the
enrolled children were relatively small at each study site, there were
limitations in the comparisons made between sites. Notably, of those
screened, 81.8% in Pakistan versus 27.3% in Mozambique were not
enrolled due to a lack of chest indrawing. This possibly could be
explained by differences in healthcare‐seeking behavior at the two
study sites and/or differences in screening procedures. Importantly,
however, great care was undertaken at both sites to ensure that all
eligibility criteria were met for enrollment. Finally, although all
nonexperts, because the onsite LUS operators/interpreters were of
different cadres at the two sites and had different backgrounds and
levels of training before the study, this may have impacted their
concordance with each other and with the expert LUS interpreters.
Among children with WHO IMCI chest‐indrawing pneumonia,
expert interpreters may achieve substantially higher interrater re-
liability for LUS compared to CXR, and LUS could be the preferred
reference standard, not only based on this study's findings, but also
other studies. Identification of pneumonia that combines LUS imaging
with clinical symptoms and signs could improve accurate diagnosis;
however, there is still a need for adequately powered studies to
validate the use of LUS for pediatric pneumonia diagnosis and a need
for a gold standard. LUS operator/interpreter and site‐level varia-
tions are clearly factors in LUS performance, and more research is
needed to better understand how LUS will perform in different LRS
and how much training is necessary to achieve good to excellent
interrater reliability.
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TABLE A1 Cross‐classified counts of expert lung ultrasound (LUS) and expert chest radiograph (CXR) pneumonia interpretations
Mozambique Pakistan
Expert CXR finala
κ
Expert CXR finala
κPositive Negative Total Positive Negative Total
Expert LUS
finalb
Positive 9 6 15 0.453 11 45 56 0.178
Negative 9 73 82 2 65 67
Total 18 79 97 13 110 123
aExpert CXR final interpretations are based on the majority interpretation for each subject among three expert CXR interpreters.
bExpert LUS final interpretations are identical to expert LUS 1 and expert LUS 2 interpretations when they agree, and when they do not agree, are
determined by the majority interpretation involving a third tiebreaker expert LUS interpreter.
TABLE A2 Cross‐classified counts of expert lung ultrasound (LUS) pneumonia interpretations
Mozambique Pakistan
Expert LUS 2
κ
Expert LUS 2
κPositive Negative Total Positive Negative Total
Expert
LUS 1
Positive 13 2 15 0.917 49 6 55 0.900
Negative 0 82 82 0 68 68
Total 13 84 97 49 74 123
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TABLE A3 Cross‐classified counts of lung ultrasound (LUS) pneumonia interpretations comparing onsite to expert interpreters
Mozambique
Onsite LUS A
κ
Onsite LUS B
κPositive Negative Total Positive Negative Total
Expert LUS
finala
Positive 7 8 15 0.597 2 13 15 0.206
Negative 0 82 82 0 82 82
Total 7 90 97 2 95 97
Pakistan
Onsite LUS C
κ
Onsite LUS D
κPositive Negative Total Positive Negative Total
Expert LUS
finala
Positive 55 1 56 0.634 55 1 56 0.619
Negative 22 45 67 23 44 67
Total 77 46 123 78 45 123
aExpert LUS final interpretations are identical to expert LUS 1 and expert LUS 2 interpretations when they agree, and when they do not agree, are
determined by the majority interpretation involving a third tiebreaker expert LUS interpreter.
TABLE A4 Cross‐classified counts of lung ultrasound (LUS) pneumonia interpretations comparing onsite LUS interpreters
Mozambique
Onsite LUS B
κPositive Negative Total
Onsite LUS A Positive 1 6 7 0.196
Negative 1 89 90
Total 2 95 97
Pakistan
Onsite LUS D
κPositive Negative Total
Onsite LUS C Positive 77 0 77 0.983
Negative 1 45 46
Total 78 45 123
TABLE A5 Expert lung ultrasound (LUS) and expert chest radiograph (CXR) pneumonia determinations among children meeting World
Health Organization Integrated Management of Childhood Illness chest‐indrawing pneumonia criteria by country, with true positive rate (TPR),
false‐positive rate (FPR), positive predictive value (PPV), and negative predictive value (NPV) using CXR as the reference standard, with 95%
confidence intervals (CI)
CXR pneumonia determination
Negative Positive Total TPR (95% CI) FPR (95% CI) PPV (95% CI) NPV (95% CI)
Mozambique: LUS
pneumonia
determination
Negative 73 9 82 0.500
(0.469, 0.531)
0.076
(0.071, 0.085)
0.600
(0.323, 0.837)
0.890
(0.802, 0.949)
Positive 6 9 15
Total 79 18 97
Pakistan: LUS pneumonia
determination
Negative 65 2 67 0.846
(0.796, 0.877)
0.409
(0.403, 0.415)
0.196
(0.102, 0.324)
0.970
(0.896, 0.996)
Positive 45 11 56
Total 110 13 123
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